🔥HOT TOPIC in #HEPATOLOGY
Selected for its clinical impact, this meta-analysis delivers critical insights into which anti-diabetic therapies may also reduce liver-related events in patients with #MASLD.
Read the full study here: https://bit.ly/4s40EgD
⏰ Deadline approaching!
Applications for two AASLD Foundation awards close Monday, Mar. 16.
Apply or share with a colleague today: https://bit.ly/3W66csX
This #WomensHistoryMonth, AASLD is celebrating the women in editorial leadership.
From the first woman to serve as Co-Editor-in-Chief of #HEPATOLOGY to the Co-Editor-in-Chief of #HepatologyCommunications, women's voices are shaping liver science and clinical knowledge.
🗣️ Share your thoughts!
Now through Mar. 27, #AASLD invites public comments for the new AASLD Practice Guideline on Pediatric #LiverTransplantation: Candidate Evaluation.
Submit your comments here: https://bit.ly/4ukuS0m
AASLD is now accepting applications for Editor-in-Chief of Hepatology Communications. This five-year leadership role offers the opportunity to shape editorial direction and elevate emerging hepatology research worldwide. Letters of Interest are due Apr. 24: https://bit.ly/4lb7kqF
The new Clinical Informatics & Digital Health SIG (CIDH SIG) connects AASLD members leveraging informatics and digital health to shape the future of hepatology.
Passionate about advancing innovation and digital transformation? Learn more: https://bit.ly/3OigJk8
Liver disease is a global challenge, and advancing care starts with understanding how #hepatology is practiced worldwide.
Participate in the Global Hepatology Survey, in collaboration with EASL, ALEH, SOLDA, and APASL.
🗓 Open through March 31
🌍 Available in 4 languages
👉 https://bit.ly/4rOPJHI
Three days left to apply for AASLD’s 2026 Transplant Hepatology Fellowship Matching Program! Pursue eligibility for an #ABIM and/or #ABP certification early when you match with a transplant hepatology fellowship. Applications close at 8 p.m. EST on March 6. https://bit.ly/3oQOYQo
AASLD is proud to collaborate with leading global organizations on a new consensus document guiding the diagnosis, staging, and management of alpha-1 antitrypsin deficiency–associated liver disease in adults.
View the consensus document in Gastroenterology. https://bit.ly/4snHRNl
Now Open: 2026 Distinguished Award Nominations
Learn more about the awards and start your nomination: https://bit.ly/3MD0xJN
In celebration of #WomensHistoryMonth, AASLD is spotlighting research that advances understanding of women’s #liverhealth and strengthens equity across #hepatology.
https://bit.ly/3ZsOS0I
Today is #RareDiseaseDay. At AASLD, we are committed to advancing education, research, and advocacy that support individuals living with rare #liverdiseases.
View these perspectives from AASLD members who are driving progress in rare liver disease research, diagnosis, and care.
"As we recognize #RareDiseaseMonth this February and #RareDiseaseDay on February 28, I confirm my own, and the entire AASLD membership’s, commitment to the rare liver disease community."
View the letter: https://bit.ly/4aCqQZE
In recognition of #RareDiseaseMonth, check out this special Rare Liver Disease collection from #AASLD publications. These articles highlight clinical expertise and innovation to accelerate discovery where it's needed most.
👉 https://bit.ly/4rFiAOG
🔥HOT TOPIC in #LiverTransplantation
This clinical trial shows that a structured, supervised exercise program significantly improves brain blood flow & cognitive function in patients with #MASLD, revealing powerful benefits that extend well beyond the #liver.
📙Full study: https://bit.ly/3NVFMZX
This #BlackHistoryMonth, AASLD spotlights the role of public policy in advancing #liverhealth equity. Evidence-based policies are essential to expanding access to prevention, early diagnosis, and treatment of liver diseases.
➡️ Learn more: https://bit.ly/4ckbExT
📙Explore the latest Practice Guideline from #AASLD and American Society of Transplantation, published in #LiverTransplantation.
➡️ Read more: https://bit.ly/4anvTNt
AASLD’s 2026 Transplant Hepatology Fellowship Matching is still accepting applications! Tailor your experience and use AASLD as your agent in matching you with an invaluable fellowship. Start your application! https://bit.ly/3oQOYQo
🔥HOT TOPIC in #HepatologyCommunications
A new systematic review of 68 randomized trials suggests albumin infusion in cirrhosis may reduce mortality & complications, while highlighting the need for more rigorous evidence to fully understand its benefits & risks.
💻Full study: https://bit.ly/4qV49p9
This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care.
#Gastroenterology Nurse Practitioner Pamela Barr, MSN, FNP-C is passionate about providing high-quality, patient-centered care across the lifespan, with a focus on serving underserved communities.
Co-Editors-in-Chief Elliot B. Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the February issue of #HepatologyCommunications.
Watch below and view the latest issue here: https://bit.ly/4sf5gBm
https://www.youtube.com/watch?v=AOUNOg3JYew
This #ValentinesDay, we’re celebrating the heart of our community, the dedicated members of #AASLD.
❤️ Thank you for all you do to advance #hepatology, promote #liverhealth, and transform lives through quality patient care.
One Month Out! The AASLD Emerging Topic Conference (ETC) is designed to examine how interconnected evidence across #liverdisease informs clinical and translational decision-making. View the program and register: https://bit.ly/3KHXpeG
🔥 HOT TOPIC in #HEPATOLOGY
This landmark study shows that vibration-controlled transient elastography provides prognostic accuracy comparable to histology in #MASLD, supporting liver stiffness measurement as a noninvasive surrogate endpoint for clinical trials.
📗Read more: https://bit.ly/4c7gulx
This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care.
Julius M. Wilder, MD, PhD, Chair of the #AASLD Public Policy Committee, shares how research, advocacy, and evidence-based policy can drive real progress toward health equity.
This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care.
Rotonya Carr, MD, FACP, FAASLD shares an important message on the resilience of our #hepatology field and the legacy of Black leadership in medicine.
@who.int is considering expanding its NCD definition to include liver disease, reflecting growing recognition of liver health as central to integrated, lifelong care and prevention. AASLD welcomes this important step for global liver health!
Learn more: https://bit.ly/4ckbExT
Your perfect match starts with AASLD’s Transplant Hepatology Fellowship Matching Program! Let AASLD be your agent in matching with reputable institutions and mentors in #transplant hepatology — apply now. https://bit.ly/3oQOYQo
Don’t miss the #WorldHepatitisSummit 2026 held in Bangkok, Thailand on Apr. 28-30.
Register by Feb. 24 to secure early bird rates. https://bit.ly/4sEMDXN
View the first message of the year from 2026 #AASLD President Dr. Saul Karpen!
https://bit.ly/4a43mLz
